Imugene Ltd: Appendix 2A
Imugene Ltd: Imugene Corporate Presentation
Imugene Ltd: Cleansing Notice
Imugene Ltd: Application for quotation of securities - IMU
Imugene Ltd: Imugene Azer-cel Webinar Presentation
Imugene Ltd: Imugene Webinar - Azer-cel Trial Update
Imugene Ltd: Three Complete Responses in Azer-Cel Phase 1b Trial
Imugene Ltd: Imugene ESG Report 2024
Imugene Ltd: Corporate Governance Statement 2024 and Appendix 4G
Imugene Ltd: Appendix 4E and Annual Report
Imugene Ltd: Release of Shares from Voluntary Escrow
Imugene Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Imugene Ltd: Notification of cessation of securities - IMU
Imugene Ltd: Notification regarding unquoted securities - IMU
Imugene Ltd: First patient dosed in Phase 1 bile tract cancer trial
Imugene Ltd: Change of Director's Interest Notice x6
Imugene Ltd: Application for quotation of securities - IMU
Imugene Ltd: Imugene Corporate Presentation
Imugene Ltd: Imugene onCARlytics Doses First Patient in IV Combination
Imugene Ltd: Imugene Presentation to Bell Potter Conference
No Data
No Data